1. Home
  2. NTRA vs STX Comparison

NTRA vs STX Comparison

Compare NTRA & STX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • STX
  • Stock Information
  • Founded
  • NTRA 2003
  • STX 1978
  • Country
  • NTRA United States
  • STX Singapore
  • Employees
  • NTRA N/A
  • STX N/A
  • Industry
  • NTRA Medical Specialities
  • STX Electronic Components
  • Sector
  • NTRA Health Care
  • STX Technology
  • Exchange
  • NTRA Nasdaq
  • STX Nasdaq
  • Market Cap
  • NTRA 18.4B
  • STX 15.5B
  • IPO Year
  • NTRA 2015
  • STX 2002
  • Fundamental
  • Price
  • NTRA $148.08
  • STX $75.78
  • Analyst Decision
  • NTRA Strong Buy
  • STX Buy
  • Analyst Count
  • NTRA 17
  • STX 20
  • Target Price
  • NTRA $176.65
  • STX $122.63
  • AVG Volume (30 Days)
  • NTRA 1.6M
  • STX 4.8M
  • Earning Date
  • NTRA 05-08-2025
  • STX 04-29-2025
  • Dividend Yield
  • NTRA N/A
  • STX 3.80%
  • EPS Growth
  • NTRA N/A
  • STX N/A
  • EPS
  • NTRA N/A
  • STX 5.45
  • Revenue
  • NTRA $1,696,911,000.00
  • STX $8,035,000,000.00
  • Revenue This Year
  • NTRA $15.33
  • STX $37.69
  • Revenue Next Year
  • NTRA $18.50
  • STX $12.79
  • P/E Ratio
  • NTRA N/A
  • STX $13.90
  • Revenue Growth
  • NTRA 56.75
  • STX 24.17
  • 52 Week Low
  • NTRA $83.13
  • STX $63.19
  • 52 Week High
  • NTRA $183.00
  • STX $115.32
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 50.83
  • STX 43.99
  • Support Level
  • NTRA $125.38
  • STX $71.30
  • Resistance Level
  • NTRA $152.66
  • STX $75.23
  • Average True Range (ATR)
  • NTRA 8.82
  • STX 4.87
  • MACD
  • NTRA 1.47
  • STX 0.39
  • Stochastic Oscillator
  • NTRA 82.19
  • STX 54.38

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About STX Seagate Technology Holdings PLC (Ireland)

Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.

Share on Social Networks: